1.30
+0.03(+2.36%)
Currency In USD
| Previous Close | 1.27 |
| Open | 1.27 |
| Day High | 1.36 |
| Day Low | 1.24 |
| 52-Week High | 11.7 |
| 52-Week Low | 1 |
| Volume | 155,298 |
| Average Volume | 137,255 |
| Market Cap | 5.7M |
| PE | -0.57 |
| EPS | -2.3 |
| Moving Average 50 Days | 1.54 |
| Moving Average 200 Days | 2.09 |
| Change | 0.03 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.49 as of December 21, 2024 at a share price of $1.3. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $3.84 as of December 21, 2024 at a share price of $1.3.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology
GlobeNewswire Inc.
Dec 18, 2024 1:30 PM GMT
INBS Intelligent Fingerprinting Drug Screening System INBS' non-invasive, cost-effective drug screening solution NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical tech
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET
GlobeNewswire Inc.
Dec 04, 2024 1:30 PM GMT
NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it will host a virtual
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results
GlobeNewswire Inc.
Nov 26, 2024 1:30 PM GMT
Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024 INBS will include data from recent PK study alongside results of method comparison study in 510(k) submission NEW YORK,